000 01474 a2200397 4500
005 20250515012251.0
264 0 _c20060216
008 200602s 0 0 eng d
022 _a0022-2623
024 7 _a10.1021/jm050467q
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aStern, Eric
245 0 0 _aNovel 4-oxo-1,4-dihydroquinoline-3-carboxamide derivatives as new CB2 cannabinoid receptors agonists: synthesis, pharmacological properties and molecular modeling.
_h[electronic resource]
260 _bJournal of medicinal chemistry
_cJan 2006
300 _a70-9 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aCrystallography, X-Ray
650 0 4 _aHumans
650 0 4 _aModels, Molecular
650 0 4 _aMolecular Structure
650 0 4 _aQuinolones
_xchemical synthesis
650 0 4 _aReceptor, Cannabinoid, CB1
_xagonists
650 0 4 _aReceptor, Cannabinoid, CB2
_xagonists
650 0 4 _aStructure-Activity Relationship
700 1 _aMuccioli, Giulio G
700 1 _aMillet, Régis
700 1 _aGoossens, Jean-François
700 1 _aFarce, Amaury
700 1 _aChavatte, Philippe
700 1 _aPoupaert, Jacques H
700 1 _aLambert, Didier M
700 1 _aDepreux, Patrick
700 1 _aHénichart, Jean-Pierre
773 0 _tJournal of medicinal chemistry
_gvol. 49
_gno. 1
_gp. 70-9
856 4 0 _uhttps://doi.org/10.1021/jm050467q
_zAvailable from publisher's website
999 _c16010729
_d16010729